Paliperidone
CAS No. 144598-75-4
Paliperidone ( 9-hydroxy Risperidone )
Catalog No. M11888 CAS No. 144598-75-4
Paliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 45 | In Stock |
|
100MG | 79 | In Stock |
|
500MG | 227 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePaliperidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionPaliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.
-
DescriptionPaliperidone(Invega) is an atypical antipsychotic. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone. It is indicated for the acute and maintenance treatment of schizophrenia.
-
Synonyms9-hydroxy Risperidone
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT; β-adrenergic receptor; Dopamine; H1 receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number144598-75-4
-
Formula Weight426.48
-
Molecular FormulaC23H27FN4O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 4mg/ml (9.38 mM); Water: <1mg/ml; Ethanol: <1mg/ml
-
SMILESCC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richelson E, Souder T. Life Sci. 2000 Nov 24;68(1):29-39.
molnova catalog
related products
-
Zolmitriptan
Zolmitriptan is a selective serotonin receptor agonist.
-
SB 206553
SB 206553 is a potent and selective 5-HT2B/5-HT2C receptor antagonist with pA2 of 8.89 for rat 5-HT2B, pKi of 7.92 for human 5-HT2C, displays >80-fold selectivity over other 5-HT receptor subtypes.
-
Gamabufotalin
Gamabufotalin, a major bufadienolide of Chansu, has been used for treatment of COX-2-mediated diseases and cancer therapy due to its desirable metabolic stability and less adverse effect.